Trial Profile
Phase I, Drug-drug Interaction Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500 When Administered Orally, in Combination With Raltegravir or Darunavir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Elsulfavirine (Primary) ; Darunavir; Raltegravir; Ritonavir
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Viriom
- 08 Jul 2015 New trial record